blindness and semaglutide A new study suggests patients taking — the active ingredient in Ozempic Wegovy — may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic Blindness Lawsuit [2026 Update]
Description
Compounded GLP-1s are not advertised
![blindness and semaglutide A new study suggests patients taking the active ingredient in Ozempic Wegovy may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic Blindness Lawsuit [2026 Update]](https://www.robertkinglawfirm.com/wp-content/uploads/2024/07/ozempic-blurry-vision.webp)
I haven't had sugar in six months
![blindness and semaglutide A new study suggests patients taking the active ingredient in Ozempic Wegovy may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic Blindness Lawsuit [2026 Update]](https://www.medicalbrief.co.za/wp-content/uploads/2024/07/RESEARCH-ISSUES-iStock-1743274641.jpg)
Improved glycemic control: Another primary and approved use of liraglutide is for glycemic control in type 2 diabetes
![blindness and semaglutide A new study suggests patients taking the active ingredient in Ozempic Wegovy may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic Blindness Lawsuit [2026 Update]](https://i.ytimg.com/vi/4GjlRv2m4aU/hq720.jpg?sqp=-oaymwEhCK4FEIIDSFryq4qpAxMIARUAAAAAGAElAADIQj0AgKJD&rs=AOn4CLD3gWkU2ZkmIxf91SyaNhulrtIsqA)
Coagulation disorders should be considered, particularly if heavy periods have been present since menarche or if there is a personal or family history of bleeding problems
![blindness and semaglutide A new study suggests patients taking the active ingredient in Ozempic Wegovy may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic Blindness Lawsuit [2026 Update]](https://futurism.com/wp-content/uploads/2024/07/experts-criticize-ozempic-blindness-study.jpg)
Compound Breakdown Each component of the Metabolic Bundle III contributes a distinct advanced signaling role: Retatrutide (15mg) studied for its triple-agonist activity across GLP-1, GIP, and glucagon receptors in metabolic research models MOTS-c (10mg) investigated as a mitochondrial-derived peptide involved in intracellular metabolic regulation and mitochondrialnuclear signaling coordination Together, these compounds allow researchers to examine system-level metabolic signaling interactions across endocrine and mitochondrial pathways
![blindness and semaglutide A new study suggests patients taking the active ingredient in Ozempic Wegovy may be at higher risk of developing an eye condition that can cause blindness. Non-arteritic anterior Ozempic Blindness Lawsuit [2026 Update]](https://berletplasticsurgery.com/wp-content/uploads/sites/308/2025/09/ezgif-8452756da14fe9-1024x576.jpg)